Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

This study explored associations between COVID-19 and dream recall frequency, and related social, health, and mental health factors.

Many people reported having odd dreams during the pandemic. Given that dreams are associated with mental health, understanding these changes could provide crucial information about wellbeing during the pandemic.

This study involving Professor Colin Espie from our Sleep and Circadian Neuroscience Institute explored associations between COVID-19 and dream recall frequency (DRF), and related social, health, and mental health factors.

The researchers carried out a cross-sectional web survey of nearly 20,000 people in 14 countries from May to July 2020. They collected data on COVID-19, mental health, sleep and dream recall frequency during the pandemic. 

The study showed that dream recall frequency was higher during the pandemic than before it, across four continents. High dream recall frequency was associated with female gender, nightmares sleep talking, sleep maintenance problems, and symptoms of REM sleep behaviour disorder. It was negatively associated with depression and anxiety. This suggests that COVID-19 is reflected in our dreams as an expression of the emotional intensity of the pandemic.

Read the full paper in Nature and Science of Sleep

Similar stories

New insights into chemogenetic designer drugs to enhance our study of behaviour

A collaborative team of researchers in DPAG and Pharmacology led by Dr Lukas Krone have uncovered striking new data demonstrating that two widely used designer drugs used to turn populations of neurons on and off in the brain cause unexpected effects on sleep. These results demonstrate a critical need to improve chemogenetic approaches in behavioural studies.

Ensuring LGBTQI+ people are treated fairly in mental health data

Andrey Kormilitzin outlines a new participatory study aimed at improving AI to take account of LGBTQI+ people so that their needs are better met by mental health services.

Community play packs inspire families to be more playful at home

A project led by Alex Hendry working with Oxford Brookes has engaged with parents and early years practitioners in a bid to help families spend more time playing with their children.

Major trials to test effectiveness of cannabidiol on psychosis

Global study involving three clinical trials will investigate the effectiveness of cannabidiol (CBD) in treating people with psychosis or psychotic symptoms, thanks to a multi-million pound grant to Oxford University.

Friendship and mental health in adolescents

Tanya Manchanda's new paper investigates the role of friendship on the mental health outcomes of adolescents